Radioactive Drug for Tests is In Short Supply


July 24, 2009

The New York Times

WASHINGTON — A global shortage of a radioactive drug crucial to tests for cardiac disease, cancer and kidney function in children is emerging because two aging nuclear reactors that provide most of the world’s supply are shut for repairs.

The 51-year-old reactor in Ontario, Canada, that produces most of this drug, a radioisotope, has been shut since May 14 because of safety problems, and it will stay shut through the end of the year, at least... Read More